Two neoplastic cell lines with unique features derived from Hodgkin's disease.
about
Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cellsHodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.Gene transfer of Hodgkin cell lines via multivalent anti-CD30 scFv displaying bacteriophage.Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated deathTumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.Cellular localization and processing of primary transcripts of exonic microRNAs.L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.Sinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9.Absence of HLA class I expression by Reed-Sternberg cells.Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.In vitro and in vivo activity of melflufen (J1)in lymphomaSurfaceome of classical Hodgkin and non-Hodgkin lymphoma.Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.Expression of mast cell tryptases in Hodgkin and Reed-Sternberg (HRS) cells.Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies.Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.History and classification of human leukemia-lymphoma cell lines.Molecular cloning and functional analysis of the CD33 promoter.Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins.Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.Inhibition of human neutrophil migration by supernatants from Hodgkin's disease-derived cell lines.Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases.Fine tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability
P2860
Q24685660-366D7D95-93D0-4C06-81BC-3840F19D9F07Q28181829-42AC5DCD-3685-47E8-8E7F-904180CB65E6Q33297034-B9ED5DEF-740E-4976-B471-3B2A46D18805Q33328662-0614CC7C-1033-47EF-99C6-9C529A35730CQ33696062-7984D69F-0BB8-4AD8-9E91-C5C262F2397AQ34358461-B1B4BA53-4F44-43AB-806D-F7C837BC4946Q34650591-617DED5D-3FFD-4D1F-A0E2-62E04F4F4B1FQ35000982-C87053F6-0A65-4B63-A235-385100CC1746Q35594354-857A696D-8873-4A21-B778-3277D43BE1F9Q35763806-CB5CD0CB-C687-41AA-AD66-B8F570F31E71Q35833799-D13CAE31-9E1D-4507-80F0-C92518BFA099Q35974144-D705CD9E-6A7A-471A-B817-EE1A2F835CDEQ36765319-3D034D9C-7A1D-4F95-B72D-F9E795BCFB0CQ38863923-A0AECDB1-9226-4DD8-AB8A-7FE56CAE59D5Q39451654-D1374354-6F54-40BB-B0C7-FD75C9B0E6E4Q39889779-6732A084-4178-42D9-9558-04A4BDEE8E14Q40049855-82EAD90F-31A7-4109-BAF9-926D04CC1600Q40381941-30EA1001-F8CE-4A1A-9C04-262005ADD82FQ40486400-045196DE-E23A-4CCA-85D5-0AE68A88245DQ40985478-8475853A-59C0-4881-9D39-09A1033EE291Q41009505-9D5852DF-BA10-439B-8B95-25780E09C106Q41151979-DA3F34B3-6040-4656-9F44-A77123278AA8Q41622818-2B44974E-150F-400D-87D2-BE3BF4F156FDQ42062045-4B134F12-32A6-45B1-AB15-B6E53BFE2F18Q42065454-B1FEA040-7AD1-43B7-A4E4-36D4CB9C5930Q42105764-9F63198A-0BFD-40BF-9335-0F82E267415AQ42142447-83054DBA-39DA-4FC4-9F29-C39204AFE51DQ43725422-1BF773EC-399D-40EE-8A15-9DE9D442CD5DQ44393825-5CA8BB64-94D1-4BB9-9ADB-FDD9D1CD8CEAQ50028326-3A9FC0F7-5913-4E3F-9824-20BF2B03733CQ58895253-717A7DC5-B60B-4742-8007-D764C44F924B
P2860
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@en
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@nl
type
label
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@en
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@nl
prefLabel
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@en
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@nl
P2093
P2860
P356
P1476
Two neoplastic cell lines with unique features derived from Hodgkin's disease.
@en
P2093
P2860
P304
P356
10.1002/IJC.2910260605
P577
1980-12-01T00:00:00Z